Halozyme Therapeutics Non-GAAP EPS of $1.60 beats by $0.08, revenue of $376.71M beats by $17.66M
Halozyme Therapeutics, Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $68.14
+6.8% in 1d after detection
Post-detection moves
1h
—
1d
+6.8%
3d
+4.2%
7d
+3.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS